Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-11-15Clinical Trial Update: A Study of Whole Brain Radiation Therapy and Capecitabine in Breast Cancer Participants With Newly Diagnosed Brain Metastasis [Phase 2]
This update reports the termination of a Phase 2 study evaluating whole brain radiation therapy in combination with capecitabine for breast …
-
CLINICAL_TRIALS trial_result · 2016-11-15Clinical Trial Update: Multiple Oncological Serial Scans Study [NA]
The clinical trial 'Multiple Oncological Serial Scans Study' focusing on breast cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-11-10Clinical Trial Update: Nodal Staging in Breast Cancer With MRL [NA]
Clinical trial NCT01609920 studying nodal staging in breast cancer with MRL has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: Patient Factors Impacting Adherence to Oral Chemotherapy
A completed clinical trial from Memorial Sloan Kettering Cancer Center evaluating how patient factors influence adherence to oral chemothera…
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: Preoperative and Intraoperative Quantification of Axillary Tumoral Load
The clinical trial evaluating preoperative and intraoperative quantification of axillary tumoral load in breast cancer has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: Partial Breast Irradiation (PBI) for Selected Patients With Early Breast Cancer [Phase 1, Phase 2]
This clinical trial update reports Phase 1 and Phase 2 results for partial breast irradiation in selected patients with early breast cancer,…
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: Educational Program in Younger Women Who Have Recently Finished Treatment for Stage I or Stage II Breast Cancer [NA]
This clinical trial update reports the completion and results posting for an educational program aimed at younger women who recently finishe…
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: PhII ICb With/Without Erbitux in MBC Pts [Phase 2]
Phase II trial evaluating an immune checkpoint blocker with or without Erbitux (cetuximab) in metastatic breast cancer; results were posted …
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer [Phase 2]
Phase 2 results update for liposomal doxorubicin (Doxil) and carboplatin in metastatic breast cancer, highlighting activity in HER2-positive…
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: Adj TC + Herceptin Early Stage Breast Cancer [Phase 2]
This clinical trial update concerns a Phase 2 study of adjuvant TC (docetaxel/cyclophosphamide) plus trastuzumab (Herceptin) in early-stage …
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: Improving Cancer-Related Outcomes in Shift Workers [NA]
A University of British Columbia-sponsored clinical trial evaluating cancer-related outcomes in shift workers with breast cancer has complet…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). [Phase 3]
A Phase 3 clinical trial in breast cancer patients receiving capecitabine (Xeloda) to prevent hand-foot syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Participants Resistant to Aromatase Inhibitor Therapy [Phase 2]
Phase 2 trial comparing GDC-0941 or GDC-0980 in combination with Fulvestrant versus Fulvestrant alone in advanced or metastatic breast cance…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Trastuzumab and Trastuzumab-MCC-DM1 Administered Intravenously and GDC-0941 Administered Orally to Patients With HER2-Positive Metastatic Breast Cancer Who Have Progressed on Previous Trastuzumab-Based Therapy [Phase 1]
Phase 1 trial evaluating the safety, tolerability, pharmacokinetics, and preliminary activity of intravenous trastuzumab, trastuzumab-MCC-DM…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study to Evaluate the Biological Activity of R1507 in Women With Operable Breast Cancer [Phase 1]
This Phase 1 trial evaluated the biological activity of the antibody R1507 in women with operable breast cancer and has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function [Phase 1]
This clinical trial update reports on a Phase 1 study of trastuzumab emtansine in HER2-positive metastatic breast cancer patients with norma…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Capecitabine Rapid Disintegrating Tablets (RDT) Versus Commercial Xeloda in Patients With Solid Tumours [Phase 1]
A Phase 1 trial comparing Capecitabine Rapid Disintegrating Tablets (RDT) to the commercial Xeloda formulation in patients with solid tumors…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Primary Chemotherapy in Patients With HER2-positive Early Breast Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating primary chemotherapy in patients with HER2-positive early …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Xeloda (Capecitabine) in Breast Cancer Patients With Central Nervous System (CNS) Progression [Phase 2]
Phase 2 study of capecitabine (Xeloda) in breast cancer patients with central nervous system progression has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study to Determine the Safety and Tolerability of Herceptin as an Adjuvant Therapy of Early Breast Cancer
A completed clinical trial evaluating the safety and tolerability of Herceptin (trastuzumab) as adjuvant therapy for early breast cancer.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Safety of Herceptin/Trastuzumab in Metastatic Breast Cancer
A completed clinical trial update assessing the safety of trastuzumab (Herceptin) in patients with metastatic breast cancer. The document su…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Non-Interventional Study of the Occurrence Rate of Non-Small Cell Lung Cancer, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey, and Diagnosis and Treatment Characteristics
This is a completed non-interventional study sponsored by Hoffmann-La Roche that assesses the occurrence rates of several cancers in Turkey …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Effect of GDC-0810 on the Pharmacokinetics of Pravastatin in Healthy Female Subjects of Non-Childbearing Potential [Phase 1]
Phase 1 pharmacokinetic study evaluating whether GDC-0810 alters the exposure of pravastatin in healthy women of non-childbearing potential.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Study of the Safety and Pharmacology of GDC-0980 in Combination With Paclitaxel With or Without Bevacizumab in Patients With Locally Recurrent or Metastatic Breast Cancer [Phase 1]
Phase 1 study evaluating safety and pharmacology of GDC-0980 in combination with paclitaxel with or without bevacizumab in patients with loc…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast Cancer [Phase 4]
This document reports the completion of a Phase 4 open-label, multicenter trial evaluating the efficacy and safety of sequential neoadjuvant…